Peri-implantitis Surgical Regenerative Therapy Using Bovine Bone Substitute With Hyaluronic Acid

NAUnknownINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

May 15, 2023

Study Completion Date

November 15, 2023

Conditions
Peri-Implantitis
Interventions
PROCEDURE

Surgery 1 (Test group)

After local anaesthesia, a full-mucoperiosteal flap will be evaluated. After granulation tissue is removed by using titanium or graphite curettes and implant surface decontamination will be performed using photodynamic therapy. Thereafter, the peri-implant bone defects in the test group will be full-filled either with bovine bone substitute with hyaluronic acid (Cerabone plus). Collagen dermal matrix (Mucoderm) will be inserted instead of a collagen membrane. Mucoderm will be fixed with 5.0 resorbable sutures. The flap will be coronally positioned and sutured with 5.0 non-resorbable sutures, respectively.

PROCEDURE

Surgery 2 (Control group)

After local anaesthesia, a full-mucoperiosteal flap will be evaluated. After granulation tissue is removed by using titanium or graphite curettes and implant surface decontamination will be performed using photodynamic therapy. Thereafter, the peri-implant bone defects in the control group will be full-filled either with bovine bone substitute (Cerabone). Collagen dermal matrix (Mucoderm) will be inserted instead of a collagen membrane. Mucoderm will be fixed with 5.0 resorbable sutures. The flap will be coronally positioned and sutured with 5.0 non-resorbable sutures, respectively.

Trial Locations (1)

11000

School of Dental Medicine, University of Belgrade, Belgrade

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Military Medical Academy, Bulgaria

OTHER

lead

Botiss Medical AG

OTHER

NCT05171582 - Peri-implantitis Surgical Regenerative Therapy Using Bovine Bone Substitute With Hyaluronic Acid | Biotech Hunter | Biotech Hunter